FOXP3 and colitis: Lee et al showed that type I IFN signaling is important for maintaining Foxp3 expression in the inflamed mucosa in a model of T cell–mediated colitis and that the administration of recombinant IFNA ameliorates the severity of colitis by increasing the number of Foxp3 cells and by improving their function37.